Efficacy and Safety of Platycodon Grandiflorus Extract(GCWB107) on Decrease of Body Fat

Inclusion Criteria: * Males and females aged between 19 and 65 years at the screening * Participants who were BMI 25\~29.9 kg/m\^2 * Participants who have fully understood the information provided about the study voluntarily decided to participate and agreed to comply with precautions Exclusion Criteria: * Participants who decrease 10% more of weight within 3 months period to the screening examination * Participants taking for products affecting body weight within 4 weeks before the screening examination(i.e., Improvement of body fat Healthy functional food, contraceptive, steroid drug treatment, female hormone drug treatment) (However, participation is possible after a 4-week withdrawal period prior to the first intake day) * Participants who drink more than 14 units/week of alcohol intake * Patients with a clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, liver biliary system, kidney and urinary system, neuropsychiatry system, musculoskeletal system, inflammatory and hematologic * Patients with diabetics who are taking oral hypoglycemic agents and insulin (at the screening) * Participants with a past history of gastrointestinal diseases (e.g., Crohn's disease) or gastrointestinal surgery (but, excluding simple cecal surgery and hernia surgery) that can affect the absorption of products of the human trial * Participants who have a history of clinically significant hypersensitivity to balloon flower and saponin components * Participants receiving antipsychotic medication within 2 months prior to the screening examination * Participants who were doubtful about drug abuse * Participants who have participated in other clinical trials within 3 months prior to the screening examination * Participants who have SBP≥180 mmHg and DBP≥110 mmHg * Menopause women * Participants who show the following relevant results in a Laboratory test * Aspartate Transaminase(AST), Alanine Transaminase(ALT) \> Reference range 3 times upper limit * Serum Creatinine \> 2.0 mg/dl * Women who are pregnant or breastfeeding * Women who may become pregnant and have not used appropriate contraceptives * Participants who the principal investigator judged inappropriate for the participant in this study because of a laboratory test result, etc